Literature DB >> 15920099

Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats.

Hiroshi Hasegawa1, Romain Meeusen, Sophie Sarre, Marc Diltoer, Maria Francesca Piacentini, Yvette Michotte.   

Abstract

The purpose of the present study was to examine the effects of an acute dose of the dual dopamine (DA) and norepinephrine (NE) reuptake inhibitor bupropion (Bup) on brain (T(brain)), body core (T(core)), and tail skin (T(tail)) temperature in freely moving rats and to simultaneously monitor the extracellular neurotransmitter concentrations in the preoptic area and anterior hypothalamus (PO/AH). A microdialysis probe was inserted in the PO/AH, and samples for NE, DA, and serotonin (5-HT) were collected every 20 min before and after the injection of 17 mg/kg of Bup, for a total sampling time of 180 min. T(core) was monitored using a biotelemetry system. T(brain) and T(tail), an index of heat loss response, were also measured. Both NE and DA levels in the PO/AH significantly increased after Bup injection compared with the baseline levels, reaching approximately 450 and 230%, respectively, 40 min after injection. There was no effect on 5-HT release. The neurotransmitter changes were accompanied by a significant decrease in T(tail) and an increase in both T(brain) and T(core) compared with the baseline levels. The present results demonstrate that inhibition of NE and DA reuptake suppresses heat loss mechanisms and elevates T(brain) and T(core) in freely moving rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920099     DOI: 10.1152/japplphysiol.00435.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Effect of caffeine on internal temperature.

Authors:  Matthew S Ganio; Lawrence E Armstrong
Journal:  Eur J Appl Physiol       Date:  2011-10-18       Impact factor: 3.078

2.  Performance and thermoregulatory effects of chronic bupropion administration in the heat.

Authors:  Bart Roelands; Hiroshi Hasegawa; Philip Watson; Maria Francesca Piacentini; Luk Buyse; Guy De Schutter; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2008-11-12       Impact factor: 3.078

3.  Caffeine, dopamine and thermoregulation.

Authors:  Bart Roelands; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2011-08-27       Impact factor: 3.078

4.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

5.  Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Authors:  Natacha Vanattou-Saïfoudine; Ruth McNamara; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2010-05-02       Impact factor: 4.530

6.  Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.

Authors:  N Vanattou-Saïfoudine; R McNamara; A Harkin
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

7.  No effect of caffeine on exercise performance in high ambient temperature.

Authors:  Bart Roelands; Luk Buyse; Frank Pauwels; Frans Delbeke; Koen Deventer; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2011-04-02       Impact factor: 3.078

Review 8.  Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature.

Authors:  Bart Roelands; Romain Meeusen
Journal:  Sports Med       Date:  2010-03-01       Impact factor: 11.136

9.  Influence of brain catecholamines on the development of fatigue in exercising rats in the heat.

Authors:  Hiroshi Hasegawa; Maria Francesca Piacentini; Sophie Sarre; Yvette Michotte; Takayuki Ishiwata; Romain Meeusen
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

10.  In vivo oxymetric analysis of mild hypercapnia upon cerebral oxygen, temperature and blood flow: markers of mood as proposed by concomitant bupropion challenge and electrochemical analysis?

Authors:  Francesco Crespi
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.